Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metronidazole for Bacterial Vaginosis in Late Pregnancy
NCT04578015Phase 4Terminated
- Sponsor
- The Ohio State University
- Start
- Apr 2021
- Primary completion
- Feb 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in bacterial vaginosis (BV) comparing Metronidazole 500 mg with Placebo (2 arms). Primary endpoint: Composite of Chorioamnionitis, Postpartum Endometritis, SSI, Wound Infection, or Other Post-cesarean Infections. Started Apr 2021; status: terminated.
02
Drugs
metronidazole
03
Conditions
bacterial vaginosis (BV)
Beyond the preview
Go deeper on NCT04578015.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04578015.